Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
주식 순위
#3676
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical... Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical firm that handles the entire process from research and development to the production, marketing, and distribution of diagnostic solutions for infectious diseases and various vaccines. The company operates extensively across China and in international markets. Its comprehensive product range offers diagnostic test kits for a multitude of infectious agents, including COVID-19, HIV, HTLV, Hepatitis, EV-71, and Tuberculosis. It also provides specific detection reagents for Hepatitis C and Syphilis. Beyond these, the portfolio includes advanced diagnostic tools such as automated immunoassays, ELISA kits, rapid diagnostic tests, and various chemiluminescence, clinical chemistry, and general immunodiagnostic reagents. Furthermore, Beijing Wantai is a developer and supplier of vaccines for Hepatitis E and human papillomavirus (HPV). The company serves a wide array of clients, including blood banks, hospitals and clinics, specialized reference laboratories, border inspection centers, blood-processing companies, and scientific research institutes. Established in 1991, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is headquartered in China's capital city, Beijing.
주가
$3.62
시가총액
$4.58B
변동 (1일)
-0.16%
변동 (1년)
-53.12%
국가
CN
거래 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
카테고리
Healthcare
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)의 EPS
June 2026 기준 EPS TTM: $-0.04
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $-0.04입니다. 2023년 말에는 회사의 EPS가 $0.14였으며, 이는 2022년의 EPS $0.55와 감소입니다.
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.의 EPS 기록 (2013 ~ 2026)
매년 말의 EPS
| 연도 | EPS | 변화 |
|---|---|---|
| 2026 (TTM) | $-0.04 | -535.00% |
| 2024 | $0.01 | -92.14% |
| 2023 | $0.14 | -74.54% |
| 2022 | $0.55 | 112.95% |
| 2021 | $0.26 | 195.53% |
| 2020 | $0.09 | 219.78% |
| 2019 | $0.03 | -30.53% |
| 2018 | $0.04 | 70.13% |
| 2017 | $0.02 | 14.36% |
| 2016 | $0.02 | 9.19% |
| 2015 | $0.02 | -4.64% |
| 2014 | $0.02 | 45.86% |
| 2013 | $0.01 | 0.00% |
유사 기업 또는 경쟁사의 EPS
| 회사 | EPS | EPS 차이 | 국가 |
|---|---|---|---|
| $17.32 | -39,916.09% |
US
|
|
| $-7.98 | 18,244.83% |
US
|
|
| $-5.29 | 12,060.92% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -63,870.11% |
NL
|
